Randox Highlights Its Innovative Diagnostic Products Revolutionizing Healthcare at MEDLAB Middle East

Randox Laboratories (Crumlin, UK) showcased the Vivalytic all-in-one molecular diagnostics solution and the Randox Discovery benchtop lab at MEDLAB Middle East which took place 24-27 January 2022 at the Dubai World Trade Centre.

The innovative platform Vivalytic developed by Randox in partnership with Bosch aims to change accessibility to molecular diagnostics. Using Randox-patented Biochip Array Technology, it is the easiest-to-use and most-comprehensive multiplex PCR platform on the market. It provides the broadest range of test options ever seen for an analyzer of its size, and also supports single-plex and low-plex testing, simplifying the processes for otherwise-complex laboratory test procedures. Depending on the test application, results will be delivered from 30 minutes. The Vivalytic is the perfect fit for any laboratory with numerous benefits to enhance testing capabilities.

Also on display at this year’s at MEDLAB Middle East was the Randox Discovery, an exciting and unique analyzer consolidating molecular and immunoassay workflows onto one compact benchtop platform. The COVID-19 diagnostic analyzer is the first to combine sample preparation techniques including extraction, PCR & Biochip Technology. Simple and easy to use, the intuitive user-interface guides the operator through the entire testing process. Built with the user and laboratory in mind, a single operator is all that is required to run up to three fully automated discovery platforms increasing operator walkaway time and ensuring rapid turnaround time of three hours to first batch results.

Related Links:
Randox Laboratories 

Visit expo >

Gold Supplier

Microplate Centrifuge & Reader

Lyra MP-Reader II

New

Microtome

M-250

New

Blood Transfusion Safety Test

ABTest Card

New

Silver Supplier

Urinalysis Dipstick Control

Dipper Urinalysis Dipstick Control